---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-064932"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2022-05-26T23:59:59+00:00"
generated_at: "2026-06-25T06:45:08.225121+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Ekso Bionics CFO Jack Glenn resigns; Controller Jerome Wong named Interim CFO

## Summary
- CFO Jack Glenn resigns effective June 17, 2022, to join another public company; no dispute or disagreement.
- Jerome Wong, company Controller since May 2017, appointed Interim CFO effective June 17, 2022.
- Wong's salary increased from $212,000 to $265,000; target bonus set at 50% of base salary.
- Wong to receive RSU award valued at $150,000, vesting over three years from June 17, 2022.
- Compensation Committee awards 300,000 RSUs to President & COO Scott Davis for his January 2022 promotion.

## SEC filing metadata
- accession: 0001104659-22-064932
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2022-05-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000110465922064932/0001104659-22-064932-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000110465922064932/tm2216972d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-064932
- JSON: https://secwatch.observer/filing/0001104659-22-064932.json
- Plain text: https://secwatch.observer/filing/0001104659-22-064932.txt

## Key facts
- Executive change
  John F. Glenn resigned as Chief Financial Officer at EKSO BIONICS HOLDINGS, INC..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: John F. Glenn notified Ekso Bionics Holdings, Inc. (the “Company”) of his decision to resign from his position as the Company’s Chief Financial Officer, effective June 17, 2022, in connection with his retention as an employee at another public company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000110465922064932/0001104659-22-064932-index.htm
- Executive change
  Jerome Wong was appointed as Interim Chief Financial Officer at EKSO BIONICS HOLDINGS, INC..
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: the Company’s board of directors (the “Board”) approved the appointment of Jerome Wong as Interim Chief Financial Officer, effective upon Mr. Glenn’s departure.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000110465922064932/0001104659-22-064932-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.